CoChat

Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Background: Prior studies have shown disparities in the uptake of cardioprotective newer glucose-lowering drugs (GLDs), including sodium-glucose cotranwsporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1a). This study aimed to characterize geographic variation in the initiation of newer GLDs and the geographic variation in the disparities in initiating these medications. Methods: Using 2017–2018 claims data from a 15% random nationwide sample of Medicare Part D beneficiaries, we identified individuals diagnosed with type 2 diabetes (T2D), who had ≥1 GLD prescriptions, and did not use SGLT2i or GLP1a in the year prior to the index date,1/1/2018. Patients were followed up for a year. The cohort was spatiotemporally linked to Dartmouth hospital-referral regions (HRRs), with each patient assigned to 1 of 306 HRRs. We performed multivariable Poisson regression to estimate adjusted initiation rates, and multivariable logistic regression to assess racial disparities in each HRR. Results: Among 795,469 individuals with T2D included in the analyses, the mean (SD) age was 73 (10) y, 53.3% were women, 12.2% were non-Hispanic Black, and 7.2% initiated a newer GLD in the follow-up year. In the adjusted model including clinical factors, compared to non-Hispanic White patients, non-Hispanic Black (initiation rate ratio, IRR [95% CI]: 0.66 [0.64–0.68]), American Indian/Alaska Native (0.74 [0.66–0.82]), Hispanic (0.85 [0.82–0.87]), and Asian/Pacific islander (0.94 [0.89–0.98]) patients were less likely to initiate newer GLDs. Significant geographic variation was observed across HRRs, with an initiation rate spanning 2.7%-13.6%. Conclusions: This study uncovered substantial geographic variation and the racial disparities in initiating newer GLDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0297208

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Adjusted initiation rate of newer GLDs and racial disparities in the initiation among Medicare beneficiaries with T2D in the entire US, by HRR. (A) Adjusted initiation rate of newer GLDs among Medicare beneficiaries with T2D, by HRR; the initiation rate was calculated using multivariable Poisson regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. Each color corresponds to quintiles of adjusted initiation rate, ranging from 2.7% to 13.6%. (B) Racial disparities in the initiation of newer GLDs among Medicare beneficiaries with T2D, by HRR; the racial disparities in the initiation of newer GLDs were determined using multivariable logistic regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. The dark red color stands for HRRs with marked disparities in the initiation of GLDs that Black people were >50% less likely to initiate the newer GLDs compared to White people (n = 22 HRRs); the orange color stands for HRRs with disparities in the initiation of GLDs that Black people were 10–50% less likely to initiate the newer GLDs compared to White people (n = 57 HRRs); the yellow color stands for HRRs appeared to have disparities in the initiation of GLDs but without satanical significance (aOR <0.9 and p>.05); the grey areas stand for HRRs with negligible racial disparities in the initiation of GLDs.
Fig 1 Adjusted initiation rate of newer GLDs and racial disparities in the initiation among Medicare beneficiaries with T2D in the entire US, by HRR. (A) Adjusted initiation rate of newer GLDs among Medicare beneficiaries with T2D, by HRR; the initiation rate was calculated using multivariable Poisson regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. Each color corresponds to quintiles of adjusted initiation rate, ranging from 2.7% to 13.6%. (B) Racial disparities in the initiation of newer GLDs among Medicare beneficiaries with T2D, by HRR; the racial disparities in the initiation of newer GLDs were determined using multivariable logistic regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. The dark red color stands for HRRs with marked disparities in the initiation of GLDs that Black people were >50% less likely to initiate the newer GLDs compared to White people (n = 22 HRRs); the orange color stands for HRRs with disparities in the initiation of GLDs that Black people were 10–50% less likely to initiate the newer GLDs compared to White people (n = 57 HRRs); the yellow color stands for HRRs appeared to have disparities in the initiation of GLDs but without satanical significance (aOR <0.9 and p>.05); the grey areas stand for HRRs with negligible racial disparities in the initiation of GLDs.CC BY · PubMed Central
Fig 2 Adjusted initiation rate of newer GLDs and racial disparities in the initiation among Medicare beneficiaries with T2D in Florida state, by HRR. (A) Adjusted initiation rate of newer GLDs among Medicare beneficiaries with T2D in Florida state, by HRR; each color corresponds to quintiles of adjusted initiation rate, ranging from 4.8% to 8.3%.(B) (C) Racial disparities in the initiation of newer GLDs among Medicare beneficiaries with T2D in Florida state, by HRR; the racial disparities in the initiation of newer GLDs were determined using multivariable logistic regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. (B) presents the racial disparities between non-Hispanic Black vs. non-Hispanic White (referent); (C) presents the racial disparities between Hispanic vs. non-Hispanic White (referent).
Fig 2 Adjusted initiation rate of newer GLDs and racial disparities in the initiation among Medicare beneficiaries with T2D in Florida state, by HRR. (A) Adjusted initiation rate of newer GLDs among Medicare beneficiaries with T2D in Florida state, by HRR; each color corresponds to quintiles of adjusted initiation rate, ranging from 4.8% to 8.3%.(B) (C) Racial disparities in the initiation of newer GLDs among Medicare beneficiaries with T2D in Florida state, by HRR; the racial disparities in the initiation of newer GLDs were determined using multivariable logistic regression model, adjusting for age, sex, Medicaid dual eligibility, rural/urban classification, T2D duration, number of GLD classes prescribed, CVD, and CKD. (B) presents the racial disparities between non-Hispanic Black vs. non-Hispanic White (referent); (C) presents the racial disparities between Hispanic vs. non-Hispanic White (referent).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 17

Metadata

Authors
Chen, W.-H., Li, Y., Yang, L., Allen, J. M., Shao, H., Donahoo, W. T., Billelo, L., Hu, X., Shenkman, E. A., Bian, J., Smith, S. M., & Guo, J.
Affiliations
  • University of Florida (US)
  • University of Pittsburgh (US)
  • University of Florida Health (US)
  • Emory University (US)
  • Rice University (US)
Corresponding author
Guo, Jingchuan
Venue
PLOS ONE
Published
2024-01-29
Volume
19
Issue
1
Pages
e0297208
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4391324556
Cited by
17
References
26
Citations by year
2026: 4 · 2025: 9 · 2024: 4
FWCI
5.57
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK R01DK133465)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, SGLT2 inhibitors, GLP-1 receptor agonists, racial disparities, regional variation, drug initiation, Medicare beneficiaries, cardiovascular benefits, hospital referral regions, non-Hispanic Black patients
MeSH terms
Sodium-Glucose Transporter 2 Inhibitors, Asian American Native Hawaiian and Pacific Islander, White, Glucagon-Like Peptide-1 Receptor Agonists, Aged, Aged, 80 and over, Black or African American, Diabetes Mellitus, Type 2, Female, Glucose, Hispanic or Latino, Humans, Male, Middle Aged, United States, American Indian or Alaska Native, Racial Groups, Medicare Part D, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes. https://app.cochat.ai/papers/10.1371/journal.pone.0297208
The paper
Chen, W.-H., Li, Y., Yang, L., Allen, J. M., Shao, H., Donahoo, W. T., Billelo, L., Hu, X., Shenkman, E. A., Bian, J., Smith, S. M., & Guo, J. (2024). Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes. PLOS ONE. https://doi.org/10.1371/journal.pone.0297208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.